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ABSTRACT
Acute respiratory infections cause significant morbidity and mortality in children. Several new respiratory viruses have 
been identified and co-detection of multiple viruses is commonly reported. This is part of a prospective study which 
aims to detect respiratory viruses by multiplex molecular method and conventional methods. Nasopharyngeal aspirate 
specimens were taken from hospitalised children aged less than 5 years with lower respiratory tract infections. These 
were tested using viral culture, immunofluorescence and Seegene Anyplex™ II RV16 real-time polymerase chain reaction. 
From 102 samples, 69 (67.6%) were positive by PCR, 12 (11.8%) positive by culture method and 13 (12.7%) positive 
by IF. A single viral pathogen was detected in 48 samples (47.1%), while 21 samples (20.6%) had co-detection of 2 to 
4 viral pathogens. Respiratory syncytial virus (RSV) was most common, detected in 17 samples (16.7% of all samples), 
followed by adenovirus and rhinovirus in 16 (15.7%), respectively. Bocavirus was detected in 15, enterovirus in 15, 
influenza A in 8 and parainfluenza-4 in 4 samples, with highest occurrences in co-detection (12/15, 10/15, 5/8 and 3/4, 
respectively). RSV was the least likely detected in co-detection (3/17). In PCR-positive samples, 54/69 (78.3%) were patients 
aged up to 24 months. Molecular methods detect more viral aetiologies than conventional methods, with simultaneous 
detection of multiple respiratory viruses. More sensitive, specific and rapid tools to determine aetiological agents could 
be incorporated into diagnostic algorithms of respiratory tract infections. Interpretations, significance, and applicability 
in clinical practice could be further explored, particularly for patients up to 2 years old.
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ABSTRAK
Jangkitan pernafasan akut mengakibatkan morbiditi dan mortaliti yang ketara pada kanak-kanak. Beberapa virus 
pernafasan yang baru telah dikenal pasti dan pengesanan beberapa virus secara serentak biasa dilaporkan. Kajian 
ini adalah sebahagian daripada kajian prospektif bertujuan untuk mengesan virus pernafasan menggunakan kaedah 
molekul multipleks dan kaedah konvensional. Spesimen aspirat nasofarinks diambil daripada kanak-kanak berumur 
kurang daripada 5 tahun yang dimasukkan ke hospital kerana jangkitan saluran pernafasan bahagian bawah. Pengujian 
adalah menggunakan pengkulturan virus,  imunofluoresen dan reaksi rantai polimerase masa sebenar menggunakan 
Seegene Anyplex ™ II RV16. Daripada 102 sampel, 69 (67.6%) positif PCR, 12 (11.8%) positif dengan kaedah kultur 
virus dan 13 (12.7%) positif dengan imunofluoresen. Patogen virus tunggal dikesan dalam 48 sampel (47.1%), manakala 
21 sampel (20.6%) mempunyai pengesanan bersama 2 hingga 4 patogen virus. Virus pernafasan sinsitium (RSV) paling 
banyak dikesan, iaitu dalam 17 sampel (16.7% daripada semua sampel), diikuti oleh adenovirus dan rhinovirus dalam 
16 (15.7%) masing-masing. Bocavirus dikesan dalam 15, enterovirus dalam 15, influenza A dalam 8 dan parainfluenza-4 
dalam 4 sampel dengan kes tertinggi dalam pengesanan bersama (12/15, 10/15, 5/8 dan 3/4 masing-masing). RSV paling 
sedikit dikesan dalam pengesanan bersama (3/17). Dalam sampel positif PCR, 54/69 (78.3%) adalah pesakit berusia 
sehingga 24 bulan. Kaedah molekul mengesan lebih banyak virus daripada kaedah konvensional dengan pengesanan 
serentak pelbagai virus pernafasan. Kaedah yang lebih sensitif, khusus dan cepat untuk menentukan agen  penyebab boleh 
dimasukkan ke dalam algoritma diagnosis jangkitan saluran pernafasan. Tafsiran keputusan ujian dan kegunaannya 
dalam amalan klinikal boleh diterokai dengan lebih lanjut, terutama untuk pesakit berusia sehingga 2 tahun.
Kata kunci: Jangkitan;  molekul; multipleks; PCR; virus pernafasan
INTRODUCTION
Acute respiratory infections cause significant morbidity 
and mortality in infants and young children (Bryce et al. 
2005; Shay et al. 1999). A systematic analysis estimated 
that in 2010, 11.9 million episodes of severe and 3.0 million 
episodes of very severe acute lower respiratory infections 
resulted in hospital admissions in young children globally 
(Nair et al. 2013). It was estimated that in 2010 there were 
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120 million episodes of pneumonia in children younger 
than 5 years and 1.3 million episodes of pneumonia led 
to death in 2011 (Walker et al. 2013). Pneumonia is a 
major cause of illness and death among children aged less 
than 5 years of age (Rudan et al. 2004). A study on lower 
respiratory tract infections in hospitalized children in 
Malaysia reported overall mortality rate of 1.3% (Nathan 
et al. 2014).
 Several new viruses have been identified in respiratory 
infections, such as human metapneumovirus (van den 
Hoogen et al. 2001), bocavirus (Allander et al. 2005), 
coronaviruses SARS (Ksiazek et al. 2003), NL63 (van der 
Hoek et al. 2004) and HKU1 (Woo et al. 2005). Molecular 
techniques enable detection of viruses not detected 
by conventional methods, such as viral culture and 
immunofluorescence, particularly the newer viruses. Co-
detection of more than one virus is increasingly recognised 
and commonly reported. Currently available molecular 
methods enable simultaneous detection of multiple viruses 
and may offer advantages over the conventional methods. 
This study aims to detect respiratory viruses by real-time 
multiplex molecular or polymerase chain reaction (PCR) 
method as well as conventional methods using viral culture 
and immunofluorescence.
MATERIALS AND METHODS
This study was part of a prospective study conducted in 
the Paediatric wards, UKM Medical Centre from 2014 to 
2015. This 900-bedded tertiary centre is located in Kuala 
Lumpur, the capital of Malaysia. Nasopharyngeal aspirate 
specimens taken from hospitalised children aged less than 
5 years, with symptoms and signs of lower respiratory 
tract infections. Demographic variables including age, 
gender and ethnic group were recorded from the laboratory 
information system. Results of viral cultures, IF and 
multiplex PCR were analysed. Ethics approval was obtained 
from the UKM Research and Ethics Committee before 
starting the study. 
SPECIMEN COLLECTION
Nasopharyngeal aspirate (NPA) specimens were obtained 
within 24 h of admission as part of routine procedure for 
investigations of respiratory tract infection. The specimens 
were placed in ice or cold packs and transported to 
the viral culture laboratory. Specimens received out of 
working hours were kept in 2-4°C and processed during 
the next working day. Specimens which did not fulfill the 
requirements for specimen collection, transport and storage 
requirements were excluded.
SPECIMEN PREPARATION
Specimens received were vortexed for 15 s to remove 
all contents from a swab into the transport media and 
filtered with 0:45 μm micro-filter to isolate the bacteria 
and fungi that could contaminate cell culture. Filtered 
specimens were then aliquoted into 2 tubes. One tube was 
used for respiratory viral culture and immunoflourescence 
(IF) testing. The second tube was used for nucleic acid 
extraction and real-time PCR. 
VIRAL CULTURE AND IMMUNOFLOURESCENCE (IF) TEST
Processing specimens for viral culture and IF were done 
according to the standard operating procedures as part of 
the routine laboratory diagnostics. The filtered specimen 
for viral culture were inoculated into cell culture (Madin 
Darby Canine Kidney (MDCK) and Hep-2) and incubated 
at 37°C (5% CO2). Cytopathic effects (CPE) in cell culture 
were observed every working day. IF tests were done using 
LIGHT DIAGNOSTICS™ Respiratory Panel Viral Screening 
& Identification IFA Kit. IF panels include Influenza A, 
Influenza B, Parainfuenza 1, 2, 3, Adenovirus and RSV. 
IF tests were done on cultures with positive CPE. Positive 
IF results were reported. Cultures with negative IF were 
re-incubated until the end of incubation period. On day 
10 of incubation, subculture and IF were performed on 
specimens without CPE. Positive IF result were reported. 
Specimens with negative IF were re-incubated until the 
end of incubation period, as per standard procedure for 
the different viruses and repeat IF test were performed 
and reported. 
MULTIPLEX REAL-TIME PCR METHOD
The second tubes from the filtered specimen were sent to 
the PCR laboratory. Nucleic acid extraction was done using 
Nimbus (Hamilton®) instrument for automated extraction. 
The reagents used were STARMag 96 Virus extraction kit for 
RV16 and cDNA Synthesis Automix (Seegene) for reverse 
transcription step in RV16, according to manufacturer 
protocol. The assay used in this study was the Anyplex™ 
II RV16 test from Seegene, Korea. It is based on Seegene’s 
proprietary DPO™ and TOCE™ technologies, which 
enables complex multiplexing in a single fluorescence 
channel, with simultaneous detection of 16 common 
respiratory viruses in a single real-time PCR, from a wide 
range of specimen types, such as nasopharyngeal aspirates 
and swabs, or bronchoalveolar lavage samples. The PCR 
is carried out using CFX96™ (Bio-Rad) instrument. 
The assay turn-around time (TAT) is less than 4 h and 
provides rapid respiratory disease screening. For results 
with more than one pathogen detection, semi-quantitative 
results could be generated (+, ++, +++) based on the 
cycle threshold values. The kit has CE Mark and In-Vitro 
Diagnostics (IVD) certification.
 A positive case is defined as the presence of any 
viral pathogen detected in the respiratory sample of a 
given patient, by PCR and/or culture method. A patient 
is considered to have a single viral infection if only 
one pathogen is detected. In patients where more than 
one pathogen is detected, patients were said to have co-
detection of viruses. 
 The pathogens detected are listed in the two panels of 
mastermixes as follows: 
  2823
Panel A: Adenovirus (AdV), Influenza A virus (FluA), 
Influenza B virus (FluB), Parainfluenza 1 virus (PIV1), 
Parainfluenza 2 virus (PIV2), Parainfluenza 3 virus (PIV3), 
Parainfluenza 4 virus (PIV4), Rhinovirus A/B/C (HRV), 
Internal control (IC).
Panel B: Respiratory syncytial virus A (RSV A), Respiratory 
syncytial virus B (RSV B), Bocavirus 1/2/3/4 (HBoV), 
Coronavirus 229E (CoV 229E), Coronavirus NL63 (CoV 
NL63), Coronavirus OC43 (CoV OC43), Metapneumovirus 
(MPV), Enterovirus (HEV), IC.
RESULTS
A total of 102 nasopharyngeal aspirate samples were tested. 
Samples from male patients constitute a total of 67 while 35 
samples were from female patients. A total of 69 samples 
(67.6%) were positive by PCR, 12 samples (11.8%) positive 
by culture method and 13 samples (12.7%) positive by 
IF. A single viral pathogen was detected in 48/69 positive 
samples (47.1% of all samples), while 21 (20.6% of all 
samples) had co-detection of 2 to 4 viral pathogens. The 
result summary for Anyplex™ II RV16 is shown in Table 1. 
 Respiratory syncytial virus (RSV) was the most 
common aetiology detected in 17 samples (16.7% of 
all samples), followed by adenovirus and rhinovirus in 
16 (15.7%), respectively. Bocavirus was detected in 15, 
enterovirus in 15, influenza A in 8 and parainfluenza-4 in 
4 samples, with the highest occurrences in co-detection 
(12/15, 10/15, 5/8 and 3/4 respectively). Results of the 
respiratory viruses detected by the three methods are shown 
in Table 2. The relatively underdiagnosed or underreported 
human metapneumovirus was detected in 2 samples, while 
coronavirus NL63 and OC43 were detected in 1 sample each. 
Results of the respiratory viruses detected stratified by age 
groups are shown in Table 3. In all PCR-positive samples, 
38/69 (55.1%) were patients aged up to 12 months and 
54/69 (78.3%) were patients aged up to 24 months. For 
most of the pathogens, more than 80% of positive cases 
were patients aged up to 24 months. The semi-quantitative 
results (+, ++, +++) that were generated by the system for 
samples with co-detection are shown in Table 4. For two 
out of 21 samples, the results of conventional methods 
agreed with the higher pathogen quantitation by PCR. 
Results of the Anyplex™ II RV16, culture and IF were 
noted to be discordant for four samples and the final results 
concluded are shown in Table 5.
TABLE 1. Summary of results for Anyplex™ II RV16
Number of 
samples
%
Total PCR-positive samples
Total negative samples
Single infection
 Co-detection
 Co-detection of 2 viruses
 Co-detection of 3 viruses
 Co-detection of 4 viruses
69/102
33/102
48/69
21/69
16/21
3/21
2/21
67.6%
32.4%
47.1%
20.6%
TABLE 2. Respiratory viruses detected by Anyplex™ II RV16, culture and IF methods
Culture 
positive 
n=102`
IF positive 
n=102
PCR 
positive 
n=102
No. of single 
detection 
n=69
No.of 
occurrence in 
co-detection
% in co-
detection
Anyplex™ II RV16
Panel A 
Adenovirus
Influenza A virus
Influenza B virus
Parainfluenza 1 virus
Parainfluenza 2 virus
Parainfluenza 3 virus
Parainfluenza 4 virus
Rhinovirus A/B/C
2
3
1
2
3 (1 PCR negative)
1
-
-
-
N/A
N/A
16
8
2
-
-
-
4
16
8
3
2
-
-
-
1
10
9
5
0
-
-
-
3
6
52.9
62.5
75
37.5
Anyplex™ II RV16
Panel B
Respiratory syncytial virus A
Respiratory syncytial virus B
Bocavirus 1/2/3/4
Metapneumovirus
Coronavirus 229E
Coronavirus NL63
Coronavirus OC43
Enterovirus
6 7 (1 culture negative)
N/A
N/A
N/A
N/A
N/A
N/A
17
-
15
2
-
1
1
15
14
-
3
1
-
1
1
5
3
-
12
1
-
0
0
10
17.6
80
50
66.7
Total individual virus detected 12 
(11.8%)
13 
(12.7%)
97 48 
(69.6%)
N/A N/A
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TABLE 3. Age groups and respiratory viruses detected
0-6 
months
7-12 
months
13-24 
months
25-60 
months
Total
Anyplex™ RV16
Panel A:
Adenovirus (AdV)
Influenza A virus (Flu A)
Influenza B virus (Flu B)
Parainfluenza 1 virus (PIV1)
Parainfluenza 2 virus (PIV2)
Parainfluenza 3 virus (PIV3)
Parainfluenza 4 virus (PIV4)
Rhinovirus A/B/C (HRV)
0
1
0
0
0
0
1
6
9
2
0
0
0
0
1
5
5
2
0
0
0
0
1
2
2
3
2
0
0
0
1
3
16
8
2
0
0
0
4
16
Anyplex™ RV16
Panel B:
Respiratory syncytial virus A (RSV A)
Respiratory syncytial virus B (RSV B)
Bocavirus 1/2/3/4 (HBoV)
Metapneumovirus (MPV)
Coronavirus 229E (CoV 229E)
Coronavirus NL63 (CoV NL63)
Coronavirus OC43 (CoV OC43)
Enterovirus (HEV)
7
0
3
1
0
0
0
6
3
0
4
1
0
0
0
5
4
0
6
0
0
0
0
3
3
0
2
0
0
1
1
1
17
0
15
2
0
1
1
15
Total number of PCR-positive samples 20 18 16 15 69
Total PCR-negative samples 5 10 8 10 33
Total number of samples 25 28 24 25 102
TABLE 4. Respiratory viruses co-detection and semi-quantitative results
Semi-quantitative results of Anyplex™ II RV16 Viral culture IF
Co-detection of 2 viruses AdV + , HEV +
AdV + , HEV ++
AdV ++ , Flu A ++
AdV ++ , HRV +
AdV +++ , MPV +
AdV++ , HRV +
Flu A +++ , HEV +
Flu A +++ , HBoV+
HBoV + , HEV ++
HBoV +, RSV A ++
HBoV +, RSV A ++
HBoV ++ , HEV +++
HRV ++ , HBoV ++
PIV4 + , HBoV ++
PIV4 +, Flu A ++
RSVA +++ , HEV ++
-
-
-
-
AdV
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
AdV
-
-
-
-
-
RSV
-
-
-
-
-
Co-detection of 3 viruses AdV +, HRV+++, HBoV+
FLU A ++ , HBoV +++ , HEV +
HRV ++, HBoV +++, HEV +
-
RSV
-
-
RSV
-
Co-detection of 4 viruses AdV + , HRV + , HBoV ++ , HEV ++
PIV4 +, AdV ++, HBoV ++, HEV +
-
-
-
-
AdV = adenovirus RSV A = respiratory syncytial virus A
Flu A = influenza A virus RSV B = respiratory syncytial virus B
Flu B = influenza B virus HBoV = bocavirus 1/2/3/4
PIV1 = parainfluenza 1 virus MPV = metapneumovirus 
PIV2 = parainfluenza 2 virus CoV 229E = Coronavirus 229E 
PIV3 = parainfluenza 3 virus CoV NL63 = Coronavirus NL63
PIV4 = parainfluenza 4 virus CoV OC43 = Coronavirus OC43
HRV = rhinovirus A/B/C HEV = Enterovirus
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DISCUSSION
Lower respiratory tract infections cause significant 
morbidity and mortality in infants and young children 
and impose a significant burden on healthcare services 
globally (Bryce et al. 2005; Nair et al. 2013). Relatively 
few studies on respiratory infections and the aetiologies 
had been conducted in this country over the years (Jason 
et al. 2016; Khor et al. 2012; Ong et al. 1982; Zamberi et 
al. 2003). Molecular methods have high sensitivity thus 
yielding not only increased detection of viral pathogens, 
but with detection of multiple viruses, which was not 
usually observed with conventional methods. Co-detection 
of more than one virus is now commonly reported. 
However, respiratory viruses such as rhinoviruses (Jacobs 
et al. 2013; Royston et al. 2016), bocavirus (Allander 
et al. 2005; Broccolo et al. 2015; Guido et al. 2016), 
enteroviruses (Jason et al. 2016; Royston et al. 2016) and 
coronaviruses (Lee et al. 2014; van der Hoek et al. 2004; 
Woo et al. 2005) and their roles as respiratory pathogens 
are less well-established. These may be further investigated 
and described by studies using the currently available 
molecular techniques.
 A wide range of positivity had been reported in studies 
using molecular methods. In this study, overall positivity 
rate was 67.6%, with a single viral pathogen detected in 
48 samples (47.1% of all samples or 69.6% of all positive 
samples). The positivity rate is quite comparable to other 
findings in this region such as Vietnam 60.9% (Yoshida 
et al. 2013), Korea 66% (Cho et al. 2013) and Taiwan 
60.2% (Lee et al. 2015). Another study in Malaysia 
found that 2708 of 10269 samples (26.4%) were positive 
for respiratory viruses. RSV accounted for 70.6% of all 
positive cases by IF and culture, followed by parainfluenza 
(13.2%), influenza (11.0%) and adenovirus (5.2%) (Khor 
et al. 2012). The differences in the rates reported are due 
to patient populations, age range, symptoms, platforms 
or methods of detection and panels of respiratory viruses 
included in the different methods.
 Most studies report RSV, rhinovirus and adenovirus 
as the most common causes of respiratory tract infections. 
RSV was reported as the most common viral cause of 
pneumonia and bronchiolitis in children aged less than 
5 years (Nair et al. 2010). This study detected RSV in 17 
samples (16.7% of all samples), followed by adenovirus 
and rhinovirus in 16 each (15.7%, respectively) among 
the most common. Influenza B was detected in 2 samples, 
while Parainfluenza-1, 2 and 3 were not detected in these 
patient samples. Metapneumovirus was positive in 2 
samples, and relatively new coronaviruses NL63 and OC43 
was also positive in one sample each.
 Co-detection of more than one pathogen reported 
ranged from 12% to more than 40% (Brand et al. 2011; 
García-Arroyo et al. 2016; Rehder et al. 2015; Roh et al. 
2008). In this study, 21 samples (20.6% of all samples 
or 30.4% of all positive samples) had more than 1 viral 
pathogen, which is within the expected range. Bocavirus 
was detected in 15 and enterovirus in 15 samples, 
influenza A in 8 and parainfluenza-4 in 4 samples, with 
the highest occurrences in co-detection (12/15, 10/15, 5/8 
and 3/4, respectively). RSV was the least likely detected 
in co-detection (3/17). Rehder et al. (2015) reported 12% 
co-detection in the 235 positive patients and similarly the 
most common viral aetiologies were adenovirus and RSV. A 
study in Spain reported a higher rate of multiple detection, 
in 30/80 samples (37.5%) (García-Arroyo et al. 2016). A 
study in Taiwan found 130/216 samples were positive by 
molecular method (60.2%), where 25 of these (19.2%) 
consisted of co-detection. The picornaviruses (rhinovirus 
and enterovirus) were most prevalent, found in 24.6% 
followed by RSV in 13.8% (Lee et al. 2015). A study in the 
Netherlands found that 73% of 177 patients was positive 
for at least one respiratory pathogen, in which 47 (26.6%) 
were co-detection. RSV (36.6%) and human rhinovirus 
(24.0%) were most frequently detected (Huijskens et al. 
2012). A study in Australia reported that 740 out of 817 
patients (90.6%) were positive, while 423 (51.8%) had co-
infection with virus and bacteria. Haemophilus influenzae 
was the predominant bacteria in cases of virus and bacteria 
co-infection (O’Grady et al. 2016). 
 There are conflicting reports on whether co-detection 
is associated with more severe respiratory disease. Multiple 
detection of respiratory pathogens were not found to be 
associated with severity of disease in some studies (Asner 
et al. 2014; Brand et al. 2011; Gagliardi et al. 2013; Lee et 
al. 2015). While in other studies, multiple detection were 
found to be associated with increased risk of moderate or 
severe disease or increased mortality (Aberle et al. 2005; 
Rehder et al. 2015). The interpretations and significance of 
detection of multiple viruses remains to be described and 
determined. It may also be difficult to differentiate between 
TABLE 5. Discordant results in four samples
Samples Semi-quantitative PCR results Viral culture IF Results concluded
1
2
3
4
Negative
HBoV +, RSV A ++
RSV A ++
Flu A ++ , HBoV +++ , HEV +
Flu A
Negative
Flu A
RSV
Flu A
RSV
Flu A
RSV
Positive Flu A
Positive RSV
Positive Flu A
Positive RSV
Flu A = influenza A virus 
RSV A = respiratory syncytial virus A 
HBoV = bocavirus 1/2/3/4 
HEV = enterovirus
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prolonged shedding and current replication. The presence 
or detection of some viruses in normal or asymptomatic 
individuals had been reported. Rhinovirus RNA could be 
detected in nasal mucus for several weeks after infection 
and some respiratory viruses such as rhinoviruses, 
human coronaviruses and bocavirus are also detected in 
asymptomatic children (Advani et al. 2012; Debiaggi et 
al. 2012; Jartti et al. 2004). 
 PCR detects viral nucleic acids and the cycle threshold 
(Ct) values of the real-time PCR may be used to generate 
the semi-quantitative results. Viral loads may be useful to 
predict infections as opposed to the presence or persistence 
of organisms. The semi-quantitative results that were 
calculated (+, ++, +++) for samples with co-detection are 
shown in Table 4, where the higher pathogen quantitation 
by PCR correlated with IF results in 2 samples. However, 
interpretations remain difficult particularly when there are 
discrepancies with the results of conventional methods, as 
shown in Table 5. Even though viral culture is generally 
regarded as the gold standard, detection by PCR which is 
known to have very high specificity indicates the presence 
of viral nucleic acids. Garcia-Arroyo et al. (2016) reported 
that in some specimens, two different molecular methods 
detected different viruses. These findings again raise the 
question on the aetiology of infection and the dilemma in 
reporting results. A lot more need to be further evaluated 
regarding semi-quantitative results and their significance, 
which is not yet established for respiratory viral infections. 
 Seegene multiplex assays have undergone several 
evaluations (Bibby et al. 2011; Bruijnesteijn van 
Coppenraeta et al. 2010; Gharabaghi et al. 2011; Roh et al. 
2008). These assays had better detection rate compared to 
viral culture method and was able to detect co-infections 
(Bruijnesteijn van Coppenraeta et al. 2010; Roh et al. 
2008). In a comparison of four multiplex PCR assays with 
IF and viral culture in children, the Seegene kit was found to 
be the most sensitive in detecting most targets (Gharabaghi 
et al. 2011). In another study, the RV15 kit was found to be 
comparable to in-house PCR system (Bibby et al. 2011). 
For the current version of Seegene Anyplex™ II RV16, 
comparison was made with 2 other multiplex RT-PCR assays 
for the detection of respiratory viruses in 201 respiratory 
samples and showed similar performance (Yun et al. 
2017). Anyplex™ II RV16 was done with RV12 assays in 
parallel, in 365 respiratory samples and comparable results 
were found (Huh et al. 2014). Other studies on Seegene 
Anyplex™ II RV16 done comparing RV16, RV15 and xTAG 
RVP (Kim et al. 2013) while Cho et al. (2013) compared 
RV16, RV15 and culture methods. They reported good 
overall sensitivity for most respiratory viruses and very 
high overall specificity. Other recent molecular methods 
available for respiratory viruses had been assessed and 
compared (Reddington et al. 2013; Zumla et al. 2014). 
Comparisons had been made in 300 samples, between 4 
multiplex panels namely Biofire FilmArray RP, Genmark 
eSensor RVP, Luminex xTAG RVPv1 and Luminex xTAG 
RVP fast multiplex (Popowitch et al. 2013). Couturier et 
al. (2013) evaluated the FilmArray® Respiratory Panel. 
Salez et al. (2015) evaluated the Cepheid Xpert® Flu/RSV 
XC assay for rapid detection of influenza A, influenza B 
and RSV.
 Cost consideration is a major hindrance for the 
rather slow implementation despite evidence of high 
performance, sensitivity and specificity of the tests. Pooling 
or batch testing is usually required or practically feasible, as 
opposed to single sample or small batch testing which would 
be quicker and more favourable, particularly for smaller 
laboratories. Current molecular techniques are also limited 
by the relative lack of standards for laboratory quality 
assurance, for benchmarking and comparison among the 
different molecular techniques and various manufacturers. 
Other limitations include the technical difficulties, PCR 
inhibition due to various reasons, sample factors, extraction 
factors, variability of respiratory viruses and primer designs 
among others. Obvious advantages include avoidance of 
time-consuming conventional methods and other costly 
tests. Knowledge of viral aetiology could potentially help 
in reducing nosocomial transmission, isolation of positive 
patients and potentially reduce length of hospitalization. 
It also allows the choice to avoid antibiotics, even though 
there may be concerns about bacterial co-infection. In a 
study of the impact of multiplex real-time PCR, detection 
of viral aetiology was associated with discontinuation of 
antibiotics in 6 of 14 children (43%) and overall 18 children 
(67%) were managed correctly without antibiotics after 
virus detection (Mayer et al. 2017). It was suggested that 
PCR had an impact on appropriate therapy for clinically 
defined viral infections. 
CONCLUSION
Findings from this study provide more information on the 
epidemiology of viral respiratory tract infections, especially 
with regards to the gap in diagnosis as well as identification 
of the newer viruses by using multiplex real-time PCR. 
Currently available molecular methods provide detection 
of more viral aetiologies than conventional methods of 
culture and IF, with advantages of higher sensitivity and 
specificity over the conventional methods. In addition, 
simultaneous detection of multiple respiratory viruses is 
increasingly recognised and needs to be further explored 
in terms of interpretations, significance, applicability, 
association with severity of disease and clinical impact. 
More sensitive and specific tools to determine the 
aetiological agents such as molecular methods could be 
incorporated into the diagnostic algorithm of respiratory 
tract infections and to ascertain their utility in clinical 
practice, particularly in patients aged up to 2 years old. 
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